Entyvio Prices, Coupons and Patient Assistance Programs
Entyvio (vedolizumab) is a member of the selective immunosuppressants drug class and is commonly used for Crohn's Disease, Crohn's Disease - Maintenance, and Ulcerative Colitis.
Entyvio prices
The cost for Entyvio intravenous powder for injection 300 mg is around $8,132 for a supply of 1 powder for injection, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
This Entyvio price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Intravenous Powder For Injection
Quantity | Per unit | Price |
---|---|---|
1 | $8,131.53 | $8,131.53 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardPlease note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Entyvio Coupons and Rebates
Entyvio offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Entyvio Connect Co-Pay Program: Eligible commercially insured patients may pay as little $5 per dose every 8 weeks; for additional information contact the program at 844-368-9846.
- Applies to:
- Entyvio
- Number of uses:
- Per prescription per year
Form more information phone: 844-368-9846 or Visit website
Entyvio Start Program: Patients who are NEW to the medication and are waiting for insurance approval or who have been denied prior authorization may receive their medication for FREE for up to 1 year; for additional information contact the program at 844-368-9846.
- Applies to:
- Entyvio
- Number of uses:
- for up to 1 year
Form more information phone: 844-368-9846 or Visit website
Entyvio Connect Bridge Program: Eligible commercially insured patients with a temporary loss or gap in commercial coverage may be provided with medication at no cost for up to 6 months; for additional information contact the program at 844-368-9846.
- Applies to:
- Entyvio
- Number of uses:
- up to 6 months
Form more information phone: 844-368-9846 or Visit website
Patient Assistance Programs for Entyvio
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: Patient Access Network Foundation (PAN)
Elligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Entyvio (vedolizumab) Injection; IV
More information please phone: 866-316-7263 Visit Website
Provider: Entyvio Patient Assistance Program
Elligibility requirements:- Contact program for details.
- At or below 500% of FPL
- Not applicable
- Must be residing in the US or US territory
- Entyvio (vedolizumab) Injection; IV
More information please phone: 855-368-9846 Visit Website
More about Entyvio (vedolizumab)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (117)
- Patient tips
- Drug images
- Compare alternatives
- En español
- Drug class: selective immunosuppressants
- FDA approval history